CIK 0001357874 · Non-accelerated filer<br>Smaller reporting company
PRECISION BIOSCIENCES INC
Sign in to watch- Ticker
- DTIL
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- May 21
- Incorporated
- DE
- Entity type
- operating
- Phone
- 919-314-5512
- Business address
- 302 EAST PETTIGREW STREET, SUITE A-100, DURHAM, NC, 27701
- Open-market buys, last 90 days
- $29,501
- in 3 filings
- Open-market sales, last 90 days
- $27,505
- in 1 filing, $28K under 10b5-1 plans
Net +$1,996. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-05-02 | SMITH J. JEFFERSON Chief Research Officer | Sale | −154 | $10.32 | $2K | 67,613 |
| 2024-05-02 | List Alan Chief Medical Officer | Sale | −290 | $10.32 | $3K | 4,488 |
| 2024-05-02 | Amoroso Michael President and CEO | Sale | −1,526 | $10.32 | $16K | 13,772 |
| 2024-05-01 | Kelly John Alexander Chief Financial Officer | Option exercise | +1,702 | 22,680 | ||
| 2024-05-01 | Kelly John Alexander Chief Financial Officer | Option exercise · Restricted Stock Units | −1,702 | 1,702 | ||
| 2024-05-01 | Scimeca Dario General Counsel and Secretary | Option exercise 10b5-1 | +918 | 5,952 | ||
| 2024-05-01 | Scimeca Dario General Counsel and Secretary | Sale · Restricted Stock Units 10b5-1 | −918 | 919 | ||
| 2024-05-01 | SMITH J. JEFFERSON Chief Research Officer | Option exercise | +519 | 67,767 | ||
| 2024-05-01 | SMITH J. JEFFERSON Chief Research Officer | Option exercise · Restricted Stock Units | −519 | 519 | ||
| 2024-05-01 | List Alan Chief Medical Officer | Option exercise | +982 | 4,778 | ||
| 2024-05-01 | List Alan Chief Medical Officer | Option exercise · Restricted Stock Units | −982 | 981 | ||
| 2024-05-01 | Amoroso Michael President and CEO | Option exercise | +3,417 | 15,298 | ||
| 2024-05-01 | Amoroso Michael President and CEO | Option exercise · Restricted Stock Units | −3,417 | 3,417 | ||
| 2024-04-30 | List Alan Chief Medical Officer | Sale | −238 | $10.03 | $2K | 3,796 |
| 2024-04-26 | List Alan Chief Medical Officer | Option exercise | +868 | 4,034 | ||
| 2024-04-26 | List Alan Chief Medical Officer | Option exercise · Restricted Stock Units | −868 | 0 | ||
| 2024-04-18 | SMITH J. JEFFERSON Chief Research Officer | Grant or award · Restricted Stock Units | +31,343 | 31,343 | ||
| 2024-04-18 | Amoroso Michael President and CEO | Grant or award · Restricted Stock Units | +111,217 | 111,217 | ||
| 2024-04-18 | Scimeca Dario General Counsel and Secretary | Grant or award · Restricted Stock Units | +25,277 | 25,277 | ||
| 2024-04-18 | Kelly John Alexander Chief Financial Officer | Grant or award · Restricted Stock Units | +41,705 | 41,705 |
Page 10 of 11 · 210 trades